Open tender · Germany · Contract notice
Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)
AOK Baden-Württemberg in Germany is inviting bids for “Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)”. Bids close on 20 October 2026.
The work
Non-exclusive discount contracts for medicinal products under § 130a Abs. 8 SGB V
- Start with specified active ingredients
- Contracts for new active ingredients can be added later
- No negotiations on contract content
- AOK sets contract content bindingly
Key facts
- Contract period
- max 30 months
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
- Price basis
- discount on contract-related medicinal products
What it takes to qualify
Worth a closer look
- The document is a German tender for pharmaceutical discount contracts and does not contain information relevant to the Indian government tender filing service schema.
Experience
- pharmazeutischer Unternehmer i. S. d. §§ 130a Abs. 8 SGB V, 78 Abs. 3 Satz 1 AMG
Policy conditions
- Bidders from certain countries are restricted
Documents to submit
- Eigenerklärung zum Inverkehrbringen, zur Zuverlässigkeit und zum Nichtvorliegen von "Russlandsanktionen"Required for all offer-related medicinal products
- Ausdruck aus dem Handelsregister (nicht älter als 6 Monate)For foreign companies, corresponding extract from professional and commercial register
- Auszug aus der Arzneimittel-Faktendatenbank (Am-FDB)For all offer-related medicinal products
- Zulassungsbescheide, Änderungsanzeigen, eidesstattliche VersicherungTo supplement Am-FDB if information is missing or outdated